Evaluating medicines: let’s use all the evidence

Mira L Harrison-Woolrych
Med J Aust 2007; 186 (12): . || doi: 10.5694/j.1326-5377.2007.tb01096.x
Published online: 18 June 2007

To the Editor: With the proposed formation of the Australia New Zealand Therapeutic Products Authority (ANZTPA), the recent viewpoint article1 and accompanying editorial2 on systems of evaluating medicines were timely. Both reports provided interesting comments on existing systems and proposals for improving these in the future. However, I would like to comment on some omissions and errors in these articles.

  • Mira L Harrison-Woolrych

  • Department of Preventive and Social Medicine, Intensive Medicines Monitoring Programme, University of Otago, Dunedin, New Zealand.

Competing interests:

The IMMP is partly funded by Medsafe, the regulatory body of the NZ Ministry of Health, and partly by unconditional donations from various sources, including some pharmaceutical companies. Funding providers do not have any role in the design, analysis or interpretation of any of the studies performed by the IMMP.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.